StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories geographic Revenue — Netherlands ($M) ($M)

Postgres DB segment_values + Form 10-K Geographic Footnote

Latest, FY2024
1,124
Period ended Dec 31, 2024
Change on a year earlier
+4.7%
1,074 in FY2023
History
15 years
Since FY2010
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGeographic Revenue — Netherlands ($M) ($M)Year on yearSource
FY2024Dec 31, 20241,124+4.7%Form 10-K (filed 2025-02-21) ↗
FY2023Dec 31, 20231,074-3.3%Form 10-K (filed 2024-02-16) ↗
FY2022Dec 31, 20221,111-5.4%Form 10-K (filed 2024-02-16) ↗
FY2021Dec 31, 20211,174+8.3%Form 10-K (filed 2024-02-16) ↗
FY2020Dec 31, 20201,084+11.2%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 2019975+4.8%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 2018930+0.1%Form 10-K (filed 2019-02-22) ↗
FY2017Dec 31, 2017929+11.9%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 2016830-2.9%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 2015855+8.5%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 2014788-17.9%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 2013960-13.3%Form 10-K (filed 2014-02-21) ↗
FY2012Dec 31, 20121,107-8.1%Form 10-K (filed 2014-02-21) ↗
FY2011Dec 31, 20111,204-39.8%Form 10-K (filed 2014-02-21) ↗
FY2010Dec 31, 20102,001–Form 10-K (filed 2013-02-15) ↗

Cite this data

StockData. (2026). Abbott Laboratories Geographic Revenue — Netherlands ($M) ($M), annual FY2010–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-geo-nl

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.